


Asakowicz Steve Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      Asakowicz Steve
                    

•   LOVELAND, CO
                      
How do I update this listing?




                                             Asakowicz Steve is based out of Loveland.    WhaleWisdom has at least 2 insider transactions (Form 3,4,5) in our database for Asakowicz Steve. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from Asakowicz Steve, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




asakowicz steve


3760 ROCKY MOUNTAIN AVENUE

LOVELAND
CO
                                                        
                                                    80538


                                                      Business Phone:
                                                      9704937272
SEC SIC CODE:2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)







Recent SEC Filings




4 filed on 06/01/2017
4 filed on 02/27/2017
4 filed on 12/30/2016
4 filed on 11/09/2016
4 filed on 08/10/2016
4 filed on 03/04/2016
4 filed on 12/31/2015
4 filed on 01/05/2015
4 filed on 11/25/2013
4 filed on 02/26/2013
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free


























Steven M. Asakowicz - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Steven M. Asakowicz
Executive Vice President, Companion Animal Health Sales at Heska Corporation


View Full Profile
Are you Steven M. Asakowicz? Claim your profile


 


Sign up for Equilar Atlas and view Steven M. Asakowicz's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Steven M. Asakowicz's  network and community.
												FOLLOW changes in Steven M. Asakowicz's employment and money-in-motion.
												CONNECT with Steven M. Asakowicz through your network of contacts.
												








Steven M. Asakowicz's Executive Work History


Current


Executive Vice President, Companion Animal Health Sales, 
Heska Corporation


Past
To view Steven M. Asakowicz's complete executive work history, sign up now
Age
51

 
 


Steven M. Asakowicz's Biography



Steven M. Asakowicz was appointed Executive Vice President, Companion Animal Health Sales in February 2013. From July 2011 to February 2013, he was employed by Cuattro, LLC as Vice President, Sales - US Veterinary and sold exclusively on behalf of Cuattro Veterinary USA, LLC. Mr. Asakowicz previously worked as Sales Director for Sound Technologies, Inc. ("Sound") from November 2002 to June 2011, including after Sound was acquired by VCA Antech, Inc. in 2004. Prior to entering the animal health market, Mr. Asakowicz spent 3.5 years employed by Smith Micro Software, Inc. as a Sales Manager and spent 7.5 years employed by AirTouch Cellular and P ...
(Read More)

			Steven M. Asakowicz was appointed Executive Vice President, Companion Animal Health Sales in February 2013. From July 2011 to February 2013, he was employed by Cuattro, LLC as Vice President, Sales - US Veterinary and sold exclusively on behalf of Cuattro Veterinary USA, LLC. Mr. Asakowicz previously worked as Sales Director for Sound Technologies, Inc. ("Sound") from November 2002 to June 2011, including after Sound was acquired by VCA Antech, Inc. in 2004. Prior to entering the animal health market, Mr. Asakowicz spent 3.5 years employed by Smith Micro Software, Inc. as a Sales Manager and spent 7.5 years employed by AirTouch Cellular and PacTel Cellular (currently Verizon Wireless) as a Corporate Account Executive. Mr. Asakowicz holds a B.A. degree from San Diego State University.
		
Source: Heska Corporation on 03/25/2015
		
	

 






Sign up for Equilar Atlas and view Steven M. Asakowicz's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Steven M. Asakowicz. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Steven M. Asakowicz's  network and community.
												FOLLOW changes in Steven M. Asakowicz's employment and money-in-motion.
												CONNECT with Steven M. Asakowicz through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Steven M. Asakowicz


















Steven M. Asakowicz's Connections (19)





Sign up now to view Steven M. Asakowicz's 19 connections »









David E. Sveen
Former Board Member, Heska Corporation









Michael A. Bent
Former Vice President, Accounting Officer and Controller, Heska Corporation









Kevin S. Wilson
Dir., Chief Executive Officer and President, Heska Corporation









Michael J. McGinley
President, Biologicals and Pharmaceuticals, Heska Corporation









Carol A. Wrenn
Board Member, Phibro Animal Health Corporation









Rodney A. Lippincott
Executive Vice President, Companion Animal Health Sales, Heska Corporation









Sharon J. Larson
Chairman of the Board, Heska Corporation









John McMahon
Vice President, Chief Financial Officer and Principal Accounting Officer, Heska Corporation









Nancy Wisnewski
Executive Vice President, Diagnostic Operations and Product Development, Heska Corporation









Steven M. Eyl
Executive Vice President, Global Sales and Marketing, Heska Corporation








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









David J. O'Connor
President and CEO, The Madison Square Garden Company









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993




















Oregon Public Employees Retirement Fund Has $2.89 Million Position in CA Inc. (CA) | Daily Political











































































Home
About/Contact
Columnists
Privacy Policy
























Headlines
Politics
Nation
World
Issues
Economy
Finance




















CA Inc. - Get News & Ratings Daily

		Enter your email address below to get the latest news and analysts' ratings for CA Inc. with our FREE daily email newsletter:



 






Follow DailyPolitical

 
 










Latest News



James Investment Research Inc. Has $333,000 Position in Kohl’s Corporation (NYSE:KSS)					

Neustar, Inc. (NSR) Shares Sold by James Investment Research Inc.					

Eqis Capital Management Inc. Increases Position in Kosmos Energy Ltd. (NYSE:KOS)					

Domtar Corporation (NYSE:UFS) Stake Decreased by James Investment Research Inc.					

Eqis Capital Management Inc. Has $352,000 Stake in China Mobile (Hong Kong) Ltd. (NYSE:CHL)					

DigitalGlobe, Inc (DGI) Shares Bought by Eqis Capital Management Inc.					

Eqis Capital Management Inc. Has $341,000 Stake in Paycom Software, Inc. (NYSE:PAYC)					

Oregon Public Employees Retirement Fund Sells 22,910 Shares of Analog Devices, Inc. (NASDAQ:ADI)					

Pioneer Natural Resources Company (NYSE:PXD) Position Maintained by Oregon Public Employees Retirement Fund					

Oregon Public Employees Retirement Fund Has $2.89 Million Position in CA Inc. (CA)					

Mobile TeleSystems OJSC (MBT) Shares Bought by OLD National Bancorp IN					

OLD National Bancorp IN Sells 938 Shares of Brocade Communications Systems, Inc. (NASDAQ:BRCD)					

Reynolds American Inc (RAI) Shares Sold by LVM Capital Management Ltd. MI					

Winslow Evans & Crocker Inc. Has $126,000 Stake in Consolidated Edison Inc (NYSE:ED)					

Oregon Public Employees Retirement Fund Cuts Stake in Atmos Energy Corporation (NYSE:ATO)					

Oregon Public Employees Retirement Fund Sells 31,968 Shares of PPG Industries, Inc. (PPG)					

Stericycle, Inc. (SRCL) Upgraded to “Sell” by BidaskClub					

The Travelers Companies (TRV) Given News Sentiment Rating of 0.15					

Peel Hunt Reiterates Hold Rating for Spectris plc (LON:SXS)					

Q3 2017 Earnings Estimate for Eagle Bancorp, Inc. Issued By FIG Partners (NASDAQ:EGBN)					





 





						Oregon Public Employees Retirement Fund Has $2.89 Million Position in CA Inc. (CA)					

						 July 25th, 2017  - 0 comments - Filed Under -
 by Tyrone Williams 


							Filed Under: Finance - SEC Filing Articles 







Tweet










Oregon Public Employees Retirement Fund cut its position in shares of  CA Inc. (NASDAQ:CA) by 5.8% during the second quarter, Holdings Channel reports. The institutional investor  owned 83,755 shares of the technology company’s stock after selling 5,200 shares during the period. Oregon Public Employees Retirement Fund’s holdings in CA were worth $2,887,000 at the end of the most recent reporting period. 
Other hedge funds and other institutional investors have also modified their holdings of the company. FMR LLC increased its position in  CA by 0.5% in the fourth quarter. FMR LLC now owns 119,299 shares of the technology company’s stock worth $3,790,000 after buying an additional 621 shares in the last quarter.  Quadrature Capital Ltd purchased a new position in  CA during the fourth quarter worth approximately $502,000.  UBS Asset Management Americas Inc. increased its position in  CA by 6.3% in the fourth quarter. UBS Asset Management Americas Inc. now owns 2,090,277 shares of the technology company’s stock worth $66,407,000 after buying an additional 123,497 shares in the last quarter.  Kentucky Retirement Systems purchased a new position in  CA during the fourth quarter worth approximately $722,000.  Finally, Kentucky Retirement Systems Insurance Trust Fund purchased a new position in  CA during the fourth quarter worth approximately $322,000. 70.74% of the stock is owned by hedge funds and other institutional investors. 
Shares of CA Inc. (CA) opened at 34.73 on Tuesday. The company has a 50 day moving average price of $33.64 and a 200 day moving average price of $32.49. The company has a market cap of $14.51 billion, a P/E ratio of 18.77 and a beta of 0.87. CA Inc. has a one year low of $30.01 and a one year high of $36.54. 




CA (NASDAQ:CA) last released its quarterly earnings data on Thursday, May 11th. The technology company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.05. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $996.59 million. CA had a return on equity of 17.15% and a net margin of 19.20%. The company’s quarterly revenue was up .3% on a year-over-year basis. During the same period in the previous year, the business earned $0.60 earnings per share.  Equities research analysts expect that  CA Inc. will post $2.38 earnings per share for the current year. 
TRADEMARK VIOLATION NOTICE: “Oregon Public Employees Retirement Fund Has $2.89 Million Position in CA Inc. (CA)” was originally  reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/07/25/oregon-public-employees-retirement-fund-has-2-89-million-position-in-ca-inc-ca.html. 
A number of research firms have commented on CA. Raymond James Financial, Inc.  reaffirmed a “market perform” rating on shares of CA in a report on Thursday, June 22nd. Citigroup Inc. increased their target price on CA from $34.00 to $36.00 and gave the stock a “neutral” rating in a report on Wednesday, June 28th. Sanford C. Bernstein  reaffirmed an “underperform” rating and set a $28.00 target price on shares of CA in a report on Wednesday, June 28th. Zacks Investment Research downgraded CA from a “buy” rating to a “hold” rating in a report on Monday, July 17th. Finally, BidaskClub downgraded CA from a “hold” rating to a “sell” rating in a report on Saturday, July 1st. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued  a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $35.10.
In other CA news, insider Ayman Sayed sold 30,194 shares of CA stock in a transaction that occurred on Wednesday, June 21st. The stock was sold at an average price of $35.62, for a total transaction of $1,075,510.28. Following the sale, the insider now directly owns 168,455 shares of the company’s stock, valued at $6,000,367.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.90% of the stock is currently owned by insiders. 
About CA
CA, Inc (CA) is engaged in providing software solutions enabling customers to plan, develop, manage and secure applications and enterprise environments across distributed, cloud, mobile and mainframe platforms. The Company operates through three business segments: Mainframe Solutions, Enterprise Solutions and Services.
Want to see what other hedge funds are holding CA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CA Inc. (NASDAQ:CA).






Receive News & Ratings for CA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



 
















 Comment on this Post

Click here to cancel reply.



Name (required)

Mail (will not be published) (required)

Website






Wordpress Hashcash needs javascript to work, but your browser has javascript disabled. Your comment will be placed in moderation!




Latest News




Jeff Sessions Spoke of Resigning After Tensions Increase with Trump





President Trump’s Tweets Complicate Already Complicated Week





World Leaders Very Critical of Paris Agreement Decision by Trump





Aide to President Trump Resigns With More Expected





Scud-Class Missile Launched by North Korea














			© DailyPolitical, LLC 2009-2017. All rights reserved. 


Privacy Policy |
			About | Columnists 
			| Contact 























































































Heska Corp (HSKA) EVP Steve Asakowicz Sells 382 Shares - American Banking News




















































Home
Get Email Updates
About
Disclaimer
Contact
Privacy Policy









 
			

















Business News
U.S. News
World News
Stock Ratings

Analysts' Upgrades
Analysts' Downgrades
Analysts' EPS Estimates
Analysts' Price Targets
Analysts' New Coverage


Corporate Earnings

Earnings Results
Earnings Guidance
Earnings Previews


Dividends
Insider Trades
Options
Press Releases






















Heska Corp - Get News & Ratings Daily

		Enter your email address below to get the latest news and analysts' ratings for Heska Corp with our FREE daily email newsletter:



 











 Recent Stories


Recent Investment Analysts’ Ratings Changes for Wizz Air Holdings PLC (WIZZ)


Travis Perkins plc (TPK) Scheduled to Post Quarterly Earnings on Wednesday


Esure Group PLC (LON:ESUR) Scheduled to Post Quarterly Earnings on Wednesday


Aviva plc (LON:AV) Scheduled to Post Quarterly Earnings on Wednesday


Aggreko plc (LON:AGK) Set to Announce Earnings on Wednesday


Recent Research Analysts’ Ratings Changes for Premier Oil PLC (PMO)


Arlington Asset Investment Corp (AI) Issues  Earnings Results


Vetr Inc. Lowers Skechers U.S.A., Inc. (SKX) to Buy


NXP Semiconductors N.V. (NASDAQ:NXPI) Upgraded by ValuEngine to “Buy”


Exact Sciences Corporation (NASDAQ:EXAS) Upgraded to “Hold” by Vetr Inc.


Delta Air Lines, Inc. (DAL) Upgraded by Vetr Inc. to “Strong-Buy”


Ford Motor Company (NYSE:F) Upgraded to Strong-Buy at Vetr Inc.


Aratana Therapeutics, Inc. (PETX) Upgraded to “Hold” at ValuEngine


PayPal Holdings, Inc. (NASDAQ:PYPL) Stock Rating Upgraded by Vetr Inc.


Alphabet Inc. (GOOGL) Upgraded to “Buy” by Vetr Inc.


Opus Bank (OPB) Stock Rating Upgraded by ValuEngine


Kroger Company (The) (NYSE:KR) Lowered to “Buy” at Vetr Inc.


Arconic Inc (NASDAQ:ARNC) Cut to “Buy” at Vetr Inc.


Snap Inc. (SNAP) Upgraded to Hold by Vetr Inc.


Bristol-Myers Squibb Company (BMY) Downgraded by Vetr Inc.





 






						Heska Corp (HSKA) EVP Steve Asakowicz Sells 382 Shares					

June 1st, 2017  • 0 comments • Filed Under •
 by ABMN Staff



							Filed Under: Insider Trades • Market News 






Tweet










Heska Corp (NASDAQ:HSKA) EVP Steve Asakowicz sold 382 shares of Heska Corp stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $100.08, for a total value of $38,230.56. Following the completion of the transaction, the executive vice president now owns 10,382 shares of the company’s stock, valued at approximately $1,039,030.56. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 
Heska Corp (HSKA) traded down 0.53% during midday trading on Thursday, reaching $98.14. The company had a trading volume of 138,525 shares. Heska Corp has a 12 month low of $32.27 and a 12 month high of $110.25. The firm’s 50-day moving average price is $99.31 and its 200 day moving average price is $85.74. The firm has a market capitalization of $698.36 million, a PE ratio of 52.57 and a beta of 0.83. 


 Get Heska Corp alerts:



Heska Corp (NASDAQ:HSKA) last issued its quarterly earnings results on Tuesday, May 2nd. The medical research company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.37. The firm had revenue of $30.38 million during the quarter, compared to the consensus estimate of $33.31 million. Heska Corp had a return on equity of 10.46% and a net margin of 7.55%. The business’s quarterly revenue was up 11.9% compared to the same quarter last year.  Equities analysts anticipate that  Heska Corp will post $1.97 earnings per share for the current fiscal year. 





TRADEMARK VIOLATION WARNING: “Heska Corp (HSKA) EVP Steve Asakowicz Sells 382 Shares” was  posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/06/01/heska-corp-hska-evp-steve-asakowicz-sells-382-shares.html. 
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Victory Capital Management Inc. purchased a new position in  Heska Corp during the first quarter worth approximately $101,000.  BNP Paribas Arbitrage SA increased its position in  Heska Corp by 1,306.0% in the first quarter. BNP Paribas Arbitrage SA now owns 1,167 shares of the medical research company’s stock worth $123,000 after buying an additional 1,084 shares in the last quarter.  Mason Street Advisors LLC purchased a new position in  Heska Corp during the first quarter worth approximately $144,000.  Asset Management One Co. Ltd. purchased a new position in  Heska Corp during the first quarter worth approximately $153,000.  Finally, PNC Financial Services Group Inc. increased its position in  Heska Corp by 199.2% in the first quarter. PNC Financial Services Group Inc. now owns 1,484 shares of the medical research company’s stock worth $155,000 after buying an additional 988 shares in the last quarter. 77.40% of the stock is currently owned by institutional investors. 
Several equities analysts have recently issued reports on the company. Zacks Investment Research upgraded Heska Corp from a “hold” rating to a “buy” rating and set a $102.00 price objective for the company in a research note on Thursday, March 2nd. Benchmark Co. lifted their price objective on Heska Corp from $78.00 to $100.00 and gave the company a “hold” rating in a research note on Monday, February 6th. B. Riley  reiterated a “neutral” rating and issued a $83.00 price objective on shares of Heska Corp in a research note on Friday, April 28th. Finally, Aegis assumed coverage on Heska Corp in a research note on Thursday. They issued a “buy” rating and a $114.50 price objective for the company. Four analysts have rated the stock with a hold rating and three have assigned  a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $95.50.
Heska Corp Company Profile
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.




Receive News & Ratings for Heska Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corp and related companies with MarketBeat.com's FREE daily email newsletter.



 































Leave a Reply

Click here to cancel reply.



Name (required)

Mail (will not be published) (required)

Website






Wordpress Hashcash needs javascript to work, but your browser has javascript disabled. Your comment will be placed in moderation!











			© Copyright American Banking and Market News 2006-2017. All rights reserved. 

Privacy Policy and Disclosures |
			About | Advertising 
			| Contact







Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.































































Stock Observer














 















 



  
 
 







Can Sears Save Its Appliances Business By Partnering with Amazon?
Jul 23rd, 2017
				Amazon and Sears have been in the news a lot lately, but for the opposite reasons: one is growing while the other is struggling. Today, though, they share bylines as it turns out that...   






Low Fees and Good Earnings Spell An Excellent Day—and Quarter—for BlackRock

							Jul 22nd, 2017						 

							BlackRock is the largest asset management firm in the world and, on Monday,...   
 





Coca Cola (UK) To Double Recycled Plastics En Route to 100 Percent Recycled Materials in Bottles

							Jul 20th, 2017						 

							Estimates suggest that plastic bottle production is slated to grow another 20...   
 





Facebook To Unveil A Standalone Oculus VR Headset Next Year

							Jul 19th, 2017						 

							Facebook will in 2018 be unveiling a new Oculus VR headset that will operate...   
 





Interactive Demos For The HomeKit System Unveiled At Apple Stores

							Jul 18th, 2017						 

							Shoppers interested in trying out Apple’s smart home system can now do so...   
 
 
 



Headlines
Toshiba Will Pay To Finish Nuclear Reactors In Southern United States

					Jun 13th, 2017				





					The Tokyo-based Toshiba Corporation said, on Saturday, that it plans to contribute $3.68 billion to press onward with building two new nuclear reactors in the US state of Georgia. The company...  
More »

DHS Could Extend The Electronics Ban On Flights To Europe
Ford Has Designed A Crib That Mimics A Car Ride To Help Babies Sleep




Health
Can Prolonged Antibiotic Use Lead to Colon Cancer?

					Apr 7th, 2017				





					So, we are now learning that long-term antibiotic use—and a somewhat ignorant medical over-reliance on them—has contributed to the rise of superbugs. These are bacteria which are mostly immune...  
More »

Can A Daily Low-Dose Aspirin Reduce Risk from Cancer Death?
At Least 1 in 5 Adults in the US Infected By High-Risk Strain of HPV
Smoking Rates Down but Population Growth Keeps Smoking Death Rate High







Economy
Oil Prices Up, but still struggling with direction

					Jun 26th, 2017				





					The price of oil has fallen dramatically this week, on the heels of growing concern over global oversupply. Some are saying, then, that there could be no better time than now to get into the...  
More »





Technology
DHS Could Extend The Electronics Ban On Flights To Europe

					May 13th, 2017				





					A ban on large electronic items such as laptops in commercial flights headed to the United States might in the near future affect passengers from European countries. Currently the ‘laptop ban’...  
More »

Reports Loss And Stock Falls Sharply As Shareholders Take A Hit
Survey Reveals That Microsoft’s Surface Tablet More Satisfying Than The iPad




 
 






















Follow @StormInvestor







Recent Posts

Northern Technologies International Corporation (NASDAQ:NTIC) Given Daily Media Impact Score of 0.23
Realty Income Corporation (NYSE:O) Receives Media Sentiment Rating of 0.21
Kennametal (KMT) Given Media Sentiment Rating of 0.21
Tesco PLC (TSCO) Given Buy Rating at HSBC Holdings plc
Brewin Dolphin Holdings plc (BRW) Stock Rating Reaffirmed by Numis Securities Ltd
Head-To-Head Contrast: EnSync (ESNC) vs. Enersys (ENS)
Head-To-Head Contrast: iPass (IPAS) vs. NQ Mobile (NQ)
ParkerVision (PRKR) & eMagin (EMAN) Critical Survey
Critical Review: Majesco Entertainment (COOL) vs. Shanda Games Limited (GAME)
$1.21 EPS Expected for Methanex Corporation (NASDAQ:MEOH) This Quarter
MakeMyTrip Limited (MMYT) Receives Daily Media Impact Rating of 0.15
-$0.23 Earnings Per Share Expected for Ironwood Pharmaceuticals, Inc. (IRWD) This Quarter
Somewhat Positive News Coverage Somewhat Likely to Impact Luxfer Holdings PLC (LXFR) Share Price
Coca-Cola Company (The) (KO) Receives News Impact Rating of 0.20
InvenSense (INVN) Receives Daily Media Impact Rating of 0.14
Intersect ENT, Inc. (NASDAQ:XENT) Receives Average Rating of “Buy” from Brokerages
Jabil Circuit, Inc. (NYSE:JBL) Given Consensus Rating of “Buy” by Analysts
Mattioli Woods plc (MTW) Receives GBX 773 Average Price Target from Analysts
Zacks: Brokerages Expect Sierra Wireless, Inc. (SWIR) to Post $0.23 Earnings Per Share
Gildan Activewear (GIL) Receiving Positive News Coverage, Accern Reports



 
 
































  Heska Corp (HSKA) Files Form 4 Insider Selling : Steve Asakowicz  Sells  382 Shares – Energy Index          Search       Heska Corp (HSKA) Files Form 4 Insider Selling : Steve Asakowicz  Sells  382 Shares       Andrew Milberg    June 6, 2017         Heska Corp (HSKA): Steve Asakowicz , EVP, Comp. Animal Health Sales of Heska Corp  sold 382 shares on Jun 1, 2017. The Insider selling transaction was reported by the company on Jun 1, 2017 to the Securities and Exchange Commission. The shares were sold at $100.06 per share for a total value of $38,230.85  , the company said in a SEC Form 4 Filing.Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 1, 2017, Michael J Mcginley  (Presi, Biologic. & Pharm.) sold 11,189 shares at $98.53 per share price.On May 31, 2017, Rod Lippincott  (EVP, Comp. Animal Health Sales) sold 11,227 shares at $98.02 per share price.Also, On May 26, 2017, Jason A Napolitano  (COO, Chief Strategist and Sec.) sold 5,000 shares at $100.50 per share price.On May 25, 2017, Nancy Wisnewski  (EVP, Diag. Ops & Prod. Dev.) sold 250 shares at $100.17 per share price.Shares of Heska Corp (HSKA) ended Tuesday, May 30, 2017 session in red amid volatile trading. The shares closed down -0.25 points or -0.26% at $97.15 with 56,044 shares getting traded. Post opening the session at $96.78, the shares hit an intraday low of $95.3463 and an intraday high of $97.88 and the price vacillated in this range throughout the day. The company has a market cap of $691 M and the number of outstanding shares has been calculated to be 71,16,016 shares. The 52-week high of Heska Corp is $110.25 and the 52-week low is $32.265.Heska Corporation develops manufactures markets sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. The Company operates in two segments: Core Companion Animal Health and Other Vaccines Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA) includes primarily for canine and feline use blood testing instruments and supplies digital imaging products software and services and single use products and services such as heartworm diagnostic tests heartworm preventive products allergy immunotherapy products and allergy testing. The Other Vaccines Pharmaceuticals and Products segment (OVP) includes private label vaccine and pharmaceutical production primarily for cattle but also for other animals including small mammals.     Andrew MilbergTo contact the author of this report, send an email to andrew.milberg@energyindexwatch.comYou might also likeBankfinancial Corp (BFIN) Files Form 4 Insider Selling : Paul A Cloutier  Sells  10,000 Shares Bankfinancial Corp (BFIN): Paul A Cloutier ,…Opko Health, Inc. (OPK) Files Form 4 Insider Buying : Gamma Investments Trust Frost  Buys  1,800 Shares Opko Health, Inc. (OPK): Gamma Investments Trust…Chesapeake Energy Corp (CHK) Files Form 4 Insider Buying : R Brad Martin  Buys  20,400 Shares Chesapeake Energy Corp (CHK): R Brad Martin…Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *   Previous PostFlushing Financial Corp (FFIC) Files Form 4 Insider Selling : Maria A Grasso  Sells  4,000 Shares Next PostCalatlantic Group, Inc. (CAA) Files Form 4 Insider Selling : Larry T Nicholson  Sells  9,000 Shares Latest Earning ReleasesThe Big Earnings of Chipotle Mexican Grill Were Overshadowed by the Data BreachDespite its Sales Spiraling Down H&M Launches a New Label- ArketRevenue Update on AdCare Health Systems(NYSEMKT:ADK)Revenue Update on Eleven Biotherapeutics Inc(NASDAQ:EBIO)     The Demand for Cloud and SSD Are Now the Prime Growth Engines for Micron As WellAlaska Airlines Planning to Absorb Virgin America by 2019Andrew Puzder Decides to Leave CKE Restaurants HoldingsSoftbank Goes Soft on Wework and Invests $300 MillionMore Departures in Uber as Two Executives LeaveVolkswagen and Audi Headquarters Raided by German Authorities      





The Norman Observer														


 













 
























 






















Trending Stock News
Penny Stock News
Market News
Stock News
Contact Us


 



Latest Headlines 




Equity Analysts at Deutsche Bank Kept their “Hold” rating for Morrison Wm Supermarkets PLC (LON:MRW). The Price Objective is GBX 225.00; Citigroup (C) Has 1.12 Sentiment
Stephen Andrade
In a report sent to investors and clients on 26 July, Morrison Wm Supermarkets PLC (LON:MRW) stock had its “Hold” Rating restate by equity analysts at Deutsche Bank. They currently have a GBX 225.00 target (more…)




BorgWarner Inc. (BWA) EPS Estimated At $0.89; 2 Analysts Bullish Syntel, Inc. (SYNT)
Hallador Energy Company (HNRG) to pay $0.04 on Aug 11, 2017; American Express Co Has 0.84 Sentiment
Brooks Automation, (BRKS) Analysts See $0.29 EPS; Trecora Resources (TREC) Shorts Raised By 11.74%
Hugoton Royalty Trust (HGT) to pay $0.00 on Aug 14, 2017; Canandaigua National Bank & Trust Company Lowered Gilead Sci  (GILD) Holding
Hexavest Has Trimmed Cisco Systems   Prop (CSCO) Position By $9.52 Million; Gilead Sciences Has 0.7 Sentiment




BofI Holding, Inc. (BOFI) Analysts See $0.51 EPS, Last Week Associated Banc (ASB) Coverage
$0.57 EPS Expected for Blucora (BCOR), Triplepoint Venture Growth Bdc C (TPVG) SI Decreased By 19.14%
EPS for Boise Cascade Co (BCC) Expected At $0.61; Subsea 7 SA (ADR) (SUBCY) Had 0 Bulls
Bank Of The West Upped Simon Ppty Group New (SPG) Holding; Mcdonalds (MCD)’s Sentiment Is 0.88
Yamana Gold Inc. (USA) (AUY) EPS Estimated At $0.03, 2 Analysts Are Bullish Gentex (GNTX) Last Week




Analysts See $-0.02 EPS for A10 Networks (ATEN), Shorts at Turning Point Brands (TPB) Raised By 10.32%
EPS for Alexion Pharmaceuticals, Inc. (ALXN) Expected At $1.08; TRICAN WELL SERVICE (TOLWF) Shorts Decreased By 19.77%
River Road Asset Management Has Decreased By $1.15 Million Its La Quinta Holdings  (LQ) Holding; Toro Company (TTC) Shorts Decreased By 7.48%
Analysts at Beaufort Securities Maintain their “Buy” rating for DekelOil Public Ltd (LON:DKL) with GBX 23.00 Target Price per Share, Jpmorgan Chase & Co (JPM)’s Sentiment Is 0.82
Analysts See $0.88 EPS for American Electric Power Company (AEP), Trinet Group (TNET) Shorts Raised By 5.92%



 

 




  Recent Posts 

Equity Analysts at Deutsche Bank Kept their “Hold” rating for Morrison Wm Supermarkets PLC (LON:MRW). The Price Objective is GBX 225.00; Citigroup (C) Has 1.12 Sentiment


BorgWarner Inc. (BWA) EPS Estimated At $0.89; 2 Analysts Bullish Syntel, Inc. (SYNT)


Hallador Energy Company (HNRG) to pay $0.04 on Aug 11, 2017; American Express Co Has 0.84 Sentiment


Brooks Automation, (BRKS) Analysts See $0.29 EPS; Trecora Resources (TREC) Shorts Raised By 11.74%


Hugoton Royalty Trust (HGT) to pay $0.00 on Aug 14, 2017; Canandaigua National Bank & Trust Company Lowered Gilead Sci  (GILD) Holding


Hexavest Has Trimmed Cisco Systems   Prop (CSCO) Position By $9.52 Million; Gilead Sciences Has 0.7 Sentiment


BofI Holding, Inc. (BOFI) Analysts See $0.51 EPS, Last Week Associated Banc (ASB) Coverage


$0.57 EPS Expected for Blucora (BCOR), Triplepoint Venture Growth Bdc C (TPVG) SI Decreased By 19.14%


EPS for Boise Cascade Co (BCC) Expected At $0.61; Subsea 7 SA (ADR) (SUBCY) Had 0 Bulls


Bank Of The West Upped Simon Ppty Group New (SPG) Holding; Mcdonalds (MCD)’s Sentiment Is 0.88


 


© Copyright 2011-2017 Norman Observer










Get the Next Big Winner in your inbox Before the Bell

Lists*Consumer Eagle






















﻿






























Heska Corporation (HSKA) EVP Steve Asakowicz Sells 382 Shares - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Heska Corporation

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Heska Corporation with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

OM Asset Management PLC (NYSE:OMAM) Receiving Somewhat Favorable Media Coverage, Study Shows
NanoString Technologies (NASDAQ:NSTG) Receiving Somewhat Favorable Media Coverage, Study Shows
-$0.29 EPS Expected for Benefitfocus, Inc. (BNFT) This Quarter
Opus Investment Management Inc. Has $1,845,000 Position in Cummins Inc. (CMI)
Comparing Nokia Corporation (NOK) & DASAN Zhone Solutions (DZSI)
Head-To-Head Survey: NetApp (NTAP) & Dot Hill Systems Corp. (HILL)
Alexandria Real Estate Equities (ARE) vs. Resource Capital Corp. (RSO) Critical Review
Castle Brands (ROX) vs. Brown Forman Corporation (BF.B) Head-To-Head Contrast
Masimo Corporation (MASI) & Penumbra (PEN) Head to Head Comparison
Brokerages Expect Nautilus Group, Inc. (The) (NLS) to Announce $0.09 Earnings Per Share
Somewhat Favorable Media Coverage Somewhat Likely to Affect American Capital Mortgage Investment Corp. (MTGE) Share Price
Somewhat Favorable News Coverage Likely to Affect Matson (MATX) Share Price
Kearny Financial (KRNY) Earns Daily Media Impact Rating of 0.19
Intra-Cellular Therapies (ITCI) Earns Daily Media Impact Rating of 0.25
Veresen Inc (TSE:VSN) Receives Average Rating of “Hold” from Analysts
Hyster-Yale Materials Handling (HY) Earns Daily Media Sentiment Rating of 0.16
O’Reilly Automotive (NASDAQ:ORLY) & Advance Auto Parts (AAP) Critical Analysis
Koninklijke Philips N.V. (NYSE:PHG) Receives Average Rating of “Buy” from Brokerages
Dover Corporation (NYSE:DOV) Given Consensus Rating of “Hold” by Analysts
FairPoint Communications (FRP) Receives Daily Media Sentiment Rating of 0.15







Heska Corporation (HSKA) EVP Steve Asakowicz Sells 382 Shares


					Posted by Chloe McGuire on Jul 6th, 2017 // No Comments




Heska Corporation (NASDAQ:HSKA) EVP Steve Asakowicz sold 382 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $100.08, for a total transaction of $38,230.56. Following the completion of the transaction, the executive vice president now owns 10,382 shares of the company’s stock, valued at approximately $1,039,030.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 
Shares of Heska Corporation (HSKA) traded down 0.89% during mid-day trading on Thursday, hitting $101.85. 27,146 shares of the stock were exchanged. Heska Corporation has a 12-month low of $37.49 and a 12-month high of $110.25. The stock has a market capitalization of $724.76 million, a P/E ratio of 54.55 and a beta of 0.81. The stock’s 50 day moving average price is $96.38 and its 200-day moving average price is $89.94. 


 Get Heska Corporation alerts:



Heska Corporation (NASDAQ:HSKA) last issued its quarterly earnings results on Tuesday, May 2nd. The medical research company reported $0.61 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.24 by $0.37. The company had revenue of $30.38 million for the quarter, compared to analysts’ expectations of $33.31 million. Heska Corporation had a return on equity of 15.20% and a net margin of 10.45%. The firm’s revenue was up 11.9% on a year-over-year basis.  On average, equities research analysts expect that  Heska Corporation will post $1.98 EPS for the current fiscal year. 
COPYRIGHT VIOLATION WARNING: “Heska Corporation (HSKA) EVP Steve Asakowicz Sells 382 Shares” was originally  published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2017/07/06/heska-corp-hska-evp-sells-38230-56-in-stock-updated-updated-updated.html. 





A number of large investors have recently modified their holdings of the company. American International Group Inc. boosted its stake in  Heska Corporation by 7.1% in the first quarter. American International Group Inc. now owns 3,754 shares of the medical research company’s stock worth $394,000 after buying an additional 248 shares in the last quarter.  BlackRock Inc. boosted its stake in  Heska Corporation by 6.2% in the third quarter. BlackRock Inc. now owns 5,413 shares of the medical research company’s stock worth $295,000 after buying an additional 318 shares in the last quarter.  Teachers Advisors LLC boosted its stake in  Heska Corporation by 4.0% in the fourth quarter. Teachers Advisors LLC now owns 9,493 shares of the medical research company’s stock worth $680,000 after buying an additional 364 shares in the last quarter.  Bogle Investment Management L P DE boosted its stake in  Heska Corporation by 0.8% in the fourth quarter. Bogle Investment Management L P DE now owns 59,489 shares of the medical research company’s stock worth $4,259,000 after buying an additional 449 shares in the last quarter.  Finally, Cadence Capital Management LLC boosted its stake in  Heska Corporation by 2.5% in the fourth quarter. Cadence Capital Management LLC now owns 21,936 shares of the medical research company’s stock worth $1,571,000 after buying an additional 525 shares in the last quarter. 81.78% of the stock is currently owned by institutional investors. 
Several research analysts have recently weighed in on HSKA shares. B. Riley  reiterated a “neutral” rating and issued a $83.00 price target on shares of Heska Corporation in a report on Friday, April 28th. Zacks Investment Research cut shares of Heska Corporation from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 3rd. Finally, Aegis began coverage on shares of Heska Corporation in a research report on Thursday, June 1st. They issued a “buy” rating and a $114.50 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and three have issued  a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $95.50.
Heska Corporation Company Profile
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.







Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 













































﻿






























Heska Corporation (NASDAQ:HSKA) EVP Sells $38,230.56 in Stock - Stock Observer













































 















 



  
 
  





















Daily Ratings & News for Heska Corporation
        	Complete the form below to receive the latest headlines and analysts' recommendationsfor Heska Corporation with our free daily email newsletter:



 





Follow @StormInvestor







Recent Posts

Northern Technologies International Corporation (NASDAQ:NTIC) Given Daily Media Impact Score of 0.23
Realty Income Corporation (NYSE:O) Receives Media Sentiment Rating of 0.21
Kennametal (KMT) Given Media Sentiment Rating of 0.21
Tesco PLC (TSCO) Given Buy Rating at HSBC Holdings plc
Brewin Dolphin Holdings plc (BRW) Stock Rating Reaffirmed by Numis Securities Ltd
Head-To-Head Contrast: EnSync (ESNC) vs. Enersys (ENS)
Head-To-Head Contrast: iPass (IPAS) vs. NQ Mobile (NQ)
ParkerVision (PRKR) & eMagin (EMAN) Critical Survey
Critical Review: Majesco Entertainment (COOL) vs. Shanda Games Limited (GAME)
$1.21 EPS Expected for Methanex Corporation (NASDAQ:MEOH) This Quarter
MakeMyTrip Limited (MMYT) Receives Daily Media Impact Rating of 0.15
-$0.23 Earnings Per Share Expected for Ironwood Pharmaceuticals, Inc. (IRWD) This Quarter
Somewhat Positive News Coverage Somewhat Likely to Impact Luxfer Holdings PLC (LXFR) Share Price
Coca-Cola Company (The) (KO) Receives News Impact Rating of 0.20
InvenSense (INVN) Receives Daily Media Impact Rating of 0.14
Intersect ENT, Inc. (NASDAQ:XENT) Receives Average Rating of “Buy” from Brokerages
Jabil Circuit, Inc. (NYSE:JBL) Given Consensus Rating of “Buy” by Analysts
Mattioli Woods plc (MTW) Receives GBX 773 Average Price Target from Analysts
Zacks: Brokerages Expect Sierra Wireless, Inc. (SWIR) to Post $0.23 Earnings Per Share
Gildan Activewear (GIL) Receiving Positive News Coverage, Accern Reports



 


Heska Corporation (NASDAQ:HSKA) EVP Sells $38,230.56 in Stock

					Posted by Brenda Bartman on Jul 6th, 2017 // No Comments 



Heska Corporation (NASDAQ:HSKA) EVP Steve Asakowicz sold 382 shares of Heska Corporation stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $100.08, for a total transaction of $38,230.56. Following the completion of the transaction, the executive vice president now owns 10,382 shares of the company’s stock, valued at approximately $1,039,030.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 
Shares of Heska Corporation (NASDAQ HSKA) opened at 102.76 on Thursday. The firm has a market cap of $731.24 million, a price-to-earnings ratio of 55.04 and a beta of 0.81. The company has a 50 day moving average of $96.38 and a 200-day moving average of $89.94. Heska Corporation has a one year low of $37.49 and a one year high of $110.25. 


 Get Heska Corporation alerts:



Heska Corporation (NASDAQ:HSKA) last issued its quarterly earnings data on Tuesday, May 2nd. The medical research company reported $0.61 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.24 by $0.37. The business had revenue of $30.38 million during the quarter, compared to the consensus estimate of $33.31 million. Heska Corporation had a net margin of 10.45% and a return on equity of 15.20%. The company’s revenue was up 11.9% on a year-over-year basis.  On average, analysts expect that  Heska Corporation will post $1.98 EPS for the current year. 
TRADEMARK VIOLATION WARNING: “Heska Corporation (NASDAQ:HSKA) EVP Sells $38,230.56 in Stock” was originally  reported by Stock Observer and is the property of of Stock Observer. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.thestockobserver.com/2017/07/06/steve-asakowicz-sells-382-shares-of-heska-corp-hska-stock-updated-updated-updated-updated.html. 




A number of research firms have recently issued reports on HSKA. B. Riley  reiterated a “neutral” rating and issued a $83.00 target price on shares of Heska Corporation in a research note on Friday, April 28th. Aegis began coverage on shares of Heska Corporation in a research note on Thursday, June 1st. They issued a “buy” rating and a $114.50 target price for the company. Finally, Zacks Investment Research cut shares of Heska Corporation from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 3rd. Four analysts have rated the stock with a hold rating and three have issued  a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $95.50.
Institutional investors have recently modified their holdings of the stock. BlackRock Inc. increased its position in shares of  Heska Corporation by 6.2% in the third quarter. BlackRock Inc. now owns 5,413 shares of the medical research company’s stock valued at $295,000 after buying an additional 318 shares during the last quarter.  Sheets Smith Wealth Management bought a new position in shares of  Heska Corporation during the third quarter valued at approximately $412,000.  Russell Investments Group Ltd. bought a new position in shares of  Heska Corporation during the fourth quarter valued at approximately $12,515,000.  Cadence Capital Management LLC increased its position in  Heska Corporation by 2.5% in the fourth quarter. Cadence Capital Management LLC now owns 21,936 shares of the medical research company’s stock valued at $1,571,000 after buying an additional 525 shares during the last quarter.  Finally, State Street Corp increased its position in  Heska Corporation by 47.3% in the fourth quarter. State Street Corp now owns 154,509 shares of the medical research company’s stock valued at $11,063,000 after buying an additional 49,611 shares during the last quarter. 81.78% of the stock is owned by institutional investors and hedge funds. 
Heska Corporation Company Profile
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.







Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.



 



 























Latest News




Northern Technologies International Corporation  Given Daily Media Impact Score of 0.23





Realty Income Corporation  Receives Media Sentiment Rating of 0.21





Kennametal  Given Media Sentiment Rating of 0.21





Tesco PLC  Given Buy Rating at HSBC Holdings plc





Brewin Dolphin Holdings plc  Stock Rating Reaffirmed by Numis Securities Ltd





Head-To-Head Contrast: EnSync  vs. Enersys 






Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website








 


 

 








































Heska Corp (HSKA.O)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Heska Corp (HSKA.O)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareMedical Equipment, Supplies & Distribution












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				HSKA.O on Consolidated Issue listed on NASDAQ Capital Market


				103.31USD
25 Jul 2017





				    Change	(% chg)


		    
						    $0.22


					            (+0.21%)
					        






Prev Close

$103.09


Open

$103.94




Day's High

$104.51


Day's Low

$103.00




Volume

48,965


Avg. Vol

99,332




52-wk High

$110.25


52-wk Low

$41.23











					Summary





Name
Age
Since
Current Position




							Kevin Wilson

43
2014

                                President, Chief Executive Officer




							John McMahon

51
2016

                                Chief Financial Officer, Vice President




							Michael McGinley

54
2013

                                President - Biologicals & Pharmaceuticals




							Jason Napolitano

48
2016

                                Chief Operating Officer, Chief Strategist and Secretary




							Steven Eyl

50
2016

                                Executive Vice President - Global Sales and Marketing




							Steven Asakowicz

49
2013

                                Executive Vice President - Companion Animal Health Sales




							Rodney Lippincott

41
2013

                                Executive Vice President - Companion Animal Health Sales




							Nancy Wisnewski

53
2016

                                Executive Vice President - Diagnostic Operations and Product Development




							Sharon Larson

55
2014

                                Lead Director




							William Aylesworth

72
2014

                                Director




							Scott Humphrey


2017

                                Director




							David Sveen

58
2013

                                Director




							Bonnie Trowbridge

68
2015

                                Director




							G. Irwin Gordon

66
2001

                                Independent Director




							Carol Wrenn

54
2013

                                Independent Director



» Insider Trading





					Biographies





Name
Description




							Kevin Wilson


					
							Mr. Kevin S. Wilson is President, Chief Executive Officer of Heska Corporation. He previously served as our President and Chief Operating Officer from February 2013. Mr. Wilson became a member of our Board of Directors in May 2014. Mr. Wilson is a founder, member and officer of Cuattro, LLC. Since 2008, he has been involved in developing technologies for radiographic imaging with Cuattro, LLC and as a founder of Cuattro Software, LLC, Cuattro Medical, LLC and Cuattro Veterinary, LLC. Mr. Wilson served on the board of various private, non-profit, and educational organizations from 2005 to 2011. He was a founder of Sound Technologies, Inc., a diagnostic imaging company, in 1996. After Sound Technologies, Inc. was sold to VCA Antech, Inc. in 2004, Mr. Wilson served as Chief Strategy Officer for VCA Antech, Inc. until 2006. Mr. Wilson attended Saddleback College.




							John McMahon


					
							Mr. John McMahon, CPA serves as Chief Financial Officer, Vice President of the Company. Mr. McMahon was appointed as Vice President, Chief Financial Officer in September 2016 and designated the Company's principal accounting officer in November 2015. He previously served as Vice President, Financial Operations & Controller from October 2015 to September 2016. From March 2014 to May 2015 he was employed by Pinnacle Ag Holdings, LLC as Vice President, Corporate Controller. Mr. McMahon previously worked as Vice President, Corporate Controller for Advanced Energy Industries from 2008 to 2014 and for Danka Office Imaging from June 2005 to June 2008 as Senior Vice President, Corporate Controller. Mr. McMahon holds an MBA in Finance from California State University, East Bay and a BS in Communications from Kutztown University.




							Michael McGinley


					
							Dr. Michael J. McGinley, Ph.D., is President - Biologicals & Pharmaceuticals of Heska Corporation, since February 2013. He previously served as President and Chief Operating Officer from January 2009 to February 2013, Vice President, Global Operations from April through December 2008, Vice President, Operations and Technical Affairs and General Manager, Heska Des Moines from January 2002 to April 2008 and in other positions beginning in June 1997. Prior to joining the Company, Dr. McGinley held positions with Bayer Animal Health and Fort Dodge Laboratories. He holds Ph.D. and M.S. degrees in Immunobiology from Iowa State University and successfully completed the Advanced Management Program at the Harvard Business School in 2008.




							Jason Napolitano


					
							Mr. Jason A. Napolitano serves as Chief Operating Officer, Chief Strategist and Secretary of the Company. He was appointed as Chief Strategist in September 2016 and as Chief Operating Officer in October 2015. He previously served as Chief Financial Officer and Executive Vice President from May 2002 until September 2016. He was appointed as the Company’s Secretary in February 2009, having previously served as Secretary from May 2002 to December 2006. Prior to joining the Company formally, he was a financial consultant. From 1990 to 2001, Mr. Napolitano held various positions at Credit Suisse First Boston, an investment bank, including Vice President in health care investment banking and Director in mergers and acquisitions. He holds a B.S. degree from Yale University.




							Steven Eyl


					
							Mr. Steven Eyl serve as Executive Vice President - Global Sales and Marketing of the Company. Previously served as the Company’s Executive Vice President, Commercial Operations from May 2013 until September 2016. Mr. Eyl was a principal of Eyl Business Services, a consulting firm, from January 2012 to May 2013. He was President of Sound Technologies, Inc. (“Sound”) from 2000 to 2011, including after Sound’s acquisition by VCA Antech, Inc. in 2004. Mr. Eyl has an extensive background in medical technology sales. He is a graduate of Indiana University.




							Steven Asakowicz


					
							Mr. Steven M. Asakowicz is Executive Vice President - Companion Animal Health Sales ofHeska Corporation, since February 2013. From July 2011 to February 2013, he was employed by Cuattro, LLC as Vice President, Sales – US Veterinary and sold exclusively on behalf of Cuattro Veterinary USA, LLC. Mr. Asakowicz previously worked as Sales Director for Sound Technologies, Inc. ("Sound") from November 2002 to June 2011, including after Sound was acquired by VCA Antech, Inc. in 2004. Prior to entering the animal health market, Mr. Asakowicz spent 3.5 years employed by Smith Micro Software, Inc. as a Sales Manager and spent 7.5 years employed by AirTouch Cellular and PacTel Cellular (currently Verizon Wireless) as a Corporate Account Executive. Mr. Asakowicz holds a B.A. degree from San Diego State University.




							Rodney Lippincott


					
							Mr. Rodney A. Lippincott is Executive Vice President, Companion Animal Health Sales of Heska Corporation, since February 2013. From July 2011 to February 2013, he was employed by Cuattro, LLC as Vice President, Sales – US Veterinary and sold exclusively on behalf of Cuattro Veterinary USA, LLC. Mr. Lippincott held various positions including Sales Director for Sound Technologies, Inc., a unit of VCA Antech, Inc., from September 2007 to June 2011. Prior to entering the animal health market, Mr. Lippincott spent 13.5 years employed by Smith Micro Software, Inc. and held positions including US and International Sales Manager and Director of Marketing. Mr. Lippincott attended Saddleback College and completed the Executive Education Marketing Management Program at Stanford University, Graduate School of Business.




							Nancy Wisnewski


					
							Dr. Nancy Wisnewski, Ph.D., serves as Executive Vice President - Diagnostic Operations and Product Development of the Company. Previously served as Executive Vice President, Product Development and Customer Support from April 2011 until September 2016. She served as Vice President, Product Development and Technical Customer Service from December 2006 to April 2011. From January 2006 to November 2006, Dr. Wisnewski was Vice President, Research and Development. Dr. Wisnewski held various positions in the Company’s Research and Development organization between 1993 and 2005. She holds a Ph.D. in Parasitology/Biochemistry from the University of Notre Dame and a B.S. in Biology from Lafayette College.




							Sharon Larson


					
							Ms. Sharon L. Riley is Lead Director of Heska Corporation, since May 2014. Ms. Riley served as Chief Executive Officer UT Southwestern University Hospitals and Vice President for University Hospitals, UT Southwestern Medical Center from 2004 to 2010. From 2000 to 2004 she was the COO at Anne Arundel Health System in Annapolis, Maryland. She held various jobs (Associate Administrator, COO and Corporate Vice President) during her employment in the Nebraska Health System from 1995 to 2000. From 1990 to 1995 she was an Assistant Administrator in the Inova Health System in Virginia. Prior to 1990 she was with Brackenridge Hospital in Austin, Texas and the Good Samaritan Hospital and Health Center in Dayton, Ohio. Ms. Riley currently serves as an Advisor to DigiWorksCorp, and as a member of the Innovation Council of Anthello Healthcare Solutions, Inc. She has also served on various boards and been involved with several community projects. Ms. Riley holds BBA (Business Administration) and MA (Hospital and Health Administration) degrees from the University of Iowa.




							William Aylesworth


					
							Mr. William A. Aylesworth is Director since May 2014 and Lead Independent Director since May 2010 of Heska Corporation. Mr. Aylesworth served as Senior Vice President from 1988 to 2003 and Chief Financial Officer of Texas Instruments Incorporated ("Texas Instruments") from 1984 to 2003. He served as Treasurer of Texas Instruments from 1982 to 2002. From 1972 to 1982, he served in treasury services, and from 1967 to 1972, he held numerous assignments in control, manufacturing and marketing for Texas Instruments. Mr. Aylesworth retired from Texas Instruments in 2003. He holds an M.S. in industrial administration from Carnegie Mellon University and a B.E.E. in electrical engineering from Cornell University.




							Scott Humphrey


					
							Mr. Scott Humphrey is Director of the company. He has been the President & CEO of One Hope United, a multi-state non-profit focused on children and family support and education services, sinceAugust 2015. Mr. Humphrey was formerly Vice Chairman, Head of U.S. Industrial Banking and Head of U.S. Mergers & Acquisitions for BMO Capital Markets Corp., where he worked from 2007 to 2015. He was an investment banker with Deutche Bank Securities from 1997 to 2007, where he was a Managing Director focused on mergers & acquisitions.




							David Sveen


					
							Dr. David E. Sveen, Ph.D., is Director of the Heska Corporation. He is the President of Cedarstone Partners, Inc., an accounting and consulting practice for nonprofit organizations, which he founded in 1993. His professional background includes 13 years in senior management with investment banking firm Griffin, Kubik, Stephens and Thompson, as well as an adjunct assistant professorship of Christian Formation and Ministry at Wheaton College from 1995 until 2013. Dr. Sveen holds a Ph.D. degree from Trinity Evangelical Divinity School in 2004, an MBA from DePaul University in 1986, an MA from Wheaton Graduate School in 2004, and a B.S. degree from Northern Illinois University in 1978.




							Bonnie Trowbridge


					
							Ms. Bonnie J. Trowbridge , CPA, is Director of the Company. Ms. Trowbridge served as Vice President, Chief Audit Executive and Risk Officer of Apollo Education Group, a publicly traded company, from 2007 to 2014. She is a retired Pricewaterhouse Coopers Audit Partner, having served with Pricewaterhouse Coopers from 1985 to 2007. Ms. Trowbridge is Chairman of the Board of Directors and treasurer of Camelot Therapeutic Horsemanship. She is a Certified Public Accountant in Arizona and California and is a member of the American Institute of Certified Public Accountants, the Arizona Society of CPA's and the Institute of Internal Auditors. Ms. Trowbridge holds a Master of Science in Accountancy from Southern Oregon State University, a Master's Degree from San Jose State University and a Bachelor's degree from Washington State University.




							G. Irwin Gordon


					
							Mr. G. Irwin Gordon is Independent Director of Heska Corporation, since May 2001. Mr. Gordon is the CEO of Landes Foods, LLC, a Dallas-based food manufacturer, a position he has held since September 2012. Mr. Gordon is also the Managing Partner of Trion LLC, a consulting firm he founded in 2000. From July 2000 until August 2001, Mr. Gordon served as President and Chief Executive Officer of Gruma Corporation, a food manufacturer. He also served as President and Chief Operating Officer of Suiza Foods Corporation, a food manufacturer and distributor, from February 1998 to October 1999. Mr. Gordon joined Suiza in August 1997 as its Executive Vice President and Chief Marketing Officer. Prior to joining Suiza, Mr. Gordon held various positions with subsidiaries of PepsiCo, Inc. ("PepsiCo"), including most recently as Senior Vice President Global Branding for Frito-Lay, Inc., from May 1996 to August 1997. From 1983 to 1992, Mr. Gordon served as President and General Manager of several international Frito-Lay companies before becoming Senior Vice President Marketing, Sales and Technology for Frito-Lay International from 1992 to 1996. Prior to joining PepsiCo in 1992, Mr. Gordon served in various capacities at the Kellogg Company. Mr. Gordon holds an Education degree from the University of British Columbia and a Management Certificate from Stanford University.




							Carol Wrenn


					
							Ms. Carol A. Wrenn is Independent Director of Heska Corporation, since January 1, 2013. She founded Sky River Helicopters, LLC in 2010 and has served as President of that company since 2010. She served as an Executive Vice President and the President of the Animal Health Division at Alpharma Inc. from 2001 to 2009. Ms. Wrenn also held the position of Chairman of the Animal Health Institute from 2007 to 2009 and was a member of the board of directors of the International Federation of Animal Health from 2002 to 2009. Prior to joining Alpharma, Ms. Wrenn held various executive positions at Honeywell International Inc. (formerly, AlliedSignal Inc.) from 1984 to 2001. She served as Business Director of Honeywell's Refrigerants, Fluorine Products Division from 2000 to 2001 and was the Commercial Director and Managing Director of Honeywell's European Fluorochemical operations from 1997 to 2000. Ms. Wrenn also held a number of positions in sales, marketing, business development and finance during her tenure with AlliedSignal. Ms. Wrenn serves as a Director of Phibro Animal Health Corporation. She holds a Bachelor's Degree from Union College and an MBA from Lehigh University.











					Basic Compensation





Name
Fiscal Year Total




							Kevin Wilson

2,347,040




							John McMahon

--




							Michael McGinley

501,279




							Jason Napolitano

463,973




							Steven Eyl

--




							Steven Asakowicz

448,239




							Rodney Lippincott

448,499




							Nancy Wisnewski

260,834




							Sharon Larson

--




							William Aylesworth

--




							Scott Humphrey

--




							David Sveen

--




							Bonnie Trowbridge

--




							G. Irwin Gordon

--




							Carol Wrenn

--



As Of 
30 Dec 2014





					Options Compensation





Name
Options
Value




							Kevin Wilson

0
0




							John McMahon

0
0




							Michael McGinley

9,499
63,156




							Jason Napolitano

1,172,206
450,236




							Steven Eyl

0
0




							Steven Asakowicz

0
0




							Rodney Lippincott

0
0




							Nancy Wisnewski

1,500
11,820




							Sharon Larson

0
0




							William Aylesworth

0
0




							Scott Humphrey

0
0




							David Sveen

0
0




							Bonnie Trowbridge

0
0




							G. Irwin Gordon

0
0




							Carol Wrenn

0
0









					Insider Trading












Name
Shares Traded
Price


Humphrey (Scott W.)
567
$0.00


Asakowicz Steve
1
$100.01


Asakowicz Steve
1
$100.06


Asakowicz Steve
382
$18.13


Asakowicz Steve
100
$100.13


Asakowicz Steve
76
$100.04


Asakowicz Steve
104
$100.00


Asakowicz Steve
100
$100.15


Lippincott Rod
950
$72.85


Mcginley Michael J
6,059
$98.53


Mcginley Michael J
5,130
$98.53


Lippincott Rod
2,895
$39.76


Lippincott Rod
2,895
$98.00


Lippincott Rod
626
$39.76


Lippincott Rod
626
$98.00


Lippincott Rod
950
$98.00


Lippincott Rod
1,478
$98.00


Lippincott Rod
2,814
$98.00


Lippincott Rod
100
$39.76


Lippincott Rod
355
$18.13


Lippincott Rod
355
$98.04


Lippincott Rod
45
$98.04


Lippincott Rod
1,964
$7.36


Lippincott Rod
1,964
$98.00


Lippincott Rod
2,814
$18.13




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareMedical Equipment, Supplies & Distribution




















